Home › Funds › Renaissance Technologies › PRME
Renaissance Technologies position in PRME
PRIME MEDICINE INC · Health Care
Latest position (Q2 2026)117.41K sh
Reported value held$433.25K
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 53.29K | $472 | New |
| Q1 2024 | 362.40K | $2.54K | Add |
| Q3 2024 | 20.00K | $77.40K | New |
| Q1 2025 | 447.60K | $890.72K | New |
| Q2 2025 | 223.40K | $551.80K | Reduce |
| Q3 2025 | 1.13M | $6.29M | Add |
| Q4 2025 | 1.15M | $3.99M | Add |
| Q1 2026 | 741.04K | $2.58M | Reduce |
| Q2 2026 | 117.41K | $433.25K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PRME
- BlackRock Inc 9.60M sh · $35.43M · Q2 2026
- ARK Invest 8.35M sh · $30.81M · Q2 2026
- Vanguard Group 6.47M sh · $22.44M · Q4 2025
- Balyasny Asset Management 3.97M sh · $14.65M · Q2 2026
- Goldman Sachs Group 3.43M sh · $12.66M · Q2 2026
- Casdin Capital 3.17M sh · $11.69M · Q2 2026
- UBS Group AG 2.79M sh · $10.31M · Q2 2026
- Geode Capital Management 2.71M sh · $10.01M · Q2 2026
- Citadel Advisors 2.35M sh · $8.68M · Q2 2026
- Fidelity Management & Research (FMR) 1.76M sh · $6.50M · Q2 2026
- Two Sigma Investments 1.52M sh · $5.63M · Q2 2026
- Farallon Capital Management 1.24M sh · $4.58M · Q2 2026